Not applicableStudy completedNCT02279537What this trial is testingReal Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMDWho this might be right forWet Macular Degeneration Bayer 593
Not applicableNot Yet RecruitingNCT06243406What this trial is testingStudy on the Biomarkers of Anti-VEGF Treatment for Choroidal NeovascularizationWho this might be right forChoroidal Neovascularization Beijing Hospital 80
Not applicableStudy completedNCT05472376What this trial is testingReal-Life Study in Diabetic Macular EdemaWho this might be right forDiabetic Macular Edema Kocaeli University 854
Post-approval studies (Phase 4)Ended earlyNCT02570789What this trial is testingEvaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF TherapyWho this might be right forClear-cell Metastatic Renal Cell Carcinoma Cliniques universitaires Saint-Luc- Université Catholique de Louvain 90
Not applicableStudy completedNCT02979665What this trial is testingChanges to the Retina Following Anti-VEGF Treatments for Diabetic Macular EdemaWho this might be right forDiabetic Macular Edema London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT02884648What this trial is testingBevacizumab in Ovarian Cancer Patients With Disease at Second-Look SurgeryWho this might be right forMalignant Neoplasms of Female Genital OrgansOvarian CancerFallopian Tube Cancer+1 more M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00025233What this trial is testingBevacizumab in Treating Patients With Persistent or Recurrent Cancer of the CervixWho this might be right forCervical Squamous Cell CarcinomaRecurrent Cervical Cancer National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)WithdrawnNCT04697953What this trial is testingEfficacy and Safety of Brolucizumab 6mg in a Treat and Extend Regimen in Patients With Neovascular Age-Related Macular Degeneration (nAMD) With Prior Anti-VEGF Exposure (PEREGRINE)Who this might be right forAge-related Macular Degeneration (AMD) Novartis Pharmaceuticals
Large-scale testing (Phase 3)WithdrawnNCT03784443What this trial is testingCombined Ranibizumab and Iluvien for Diabetic Macular OedemaWho this might be right forDiabetic Macular EdemaDiabetes Imperial College London
Early research (Phase 1)Study completedNCT00454649What this trial is testingInvestigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid TumorWho this might be right forNeoplasms Pfizer 102
Testing effectiveness (Phase 2)Study completedNCT00055913What this trial is testingBevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+10 more National Cancer Institute (NCI) 58
Not applicableNot Yet RecruitingNCT07009574What this trial is testingThe Treatment Burden of Myopic Choroidal NeovascularizationWho this might be right forMyopic Choroidal NeovascularisationAnti-VEGF TreatmentBurden Policlinico Gaspare Rodolico - San Marco Catania 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06449209What this trial is testingSafety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With ChemotherapyWho this might be right forExtensive-stage Small-cell Lung CancerSmall-cell Lung Cancer BioNTech SE 110
Testing effectiveness (Phase 2)Study completedNCT00527475What this trial is testingRanibizumab and Reduced Fluence PDT for AMDWho this might be right forMacular Degeneration Texas Retina Associates 60
Early research (Phase 1)Study completedNCT00793975What this trial is testingStudy of IMC-1121B in Patients With Tumors That Have Not Responded to TherapyWho this might be right forAdvanced Solid Tumors Eli Lilly and Company 37
Testing effectiveness (Phase 2)Ended earlyNCT00066677What this trial is testingBevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Fox Chase Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT00049322What this trial is testingChemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With SurgeryWho this might be right forLiver Cancer Jonsson Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01945866What this trial is testingPhase II Combination Steroid and Anti-VEGF for Persistent DMEWho this might be right forDiabetic Macular Edema Jaeb Center for Health Research 129
Not applicableStudy completedNCT02251366What this trial is testingNVAMD Satellite StudyWho this might be right forNeovascular Age Related Macular Degeneration Johns Hopkins University 66
Post-approval studies (Phase 4)Study completedNCT03117634What this trial is testingAn Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal VasculopathyWho this might be right forAge Related Macular DegenerationPolypoidal Choroidal Vasculopathy Singapore National Eye Centre 54